LR, "top line" usually refers to primary outcome measures as stated in the study protocol (which we don't have, but importantly, FDA does) and usually also in ClinicalTrials.gov filing. In prurisol trial case, PASI 75 response and adverse effects.
Nice reminder that p2a trial press release. I expect IPIX will waste no time between data lock and releasing 'top line' results, but one week might be pushing it with this particular trial.
P.S. Next time when some financial conclusions pop into my hard head, I promise to ask you first if they make any sense. It clearly is better that way.
News 
Market Data 
Discover 
AI
